Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-02-18 @ 2:26 AM
Study NCT ID:
NCT04837859
Status:
RECRUITING
Last Update Posted:
2024-07-26
First Post:
2021-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Individualized Immunotherapy in Early-Stage Unfavorable Classical Hodgkin Lymphoma
Sponsor:
University of Cologne
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Classical Hodgkin Lymphoma | View |
Keywords: